Multisite Controlled Study of OROS Methylphenidate in the Treatment of Adolescents With Attention-Deficit/Hyperactivity Disorder - Concepedia

Concepedia

Publication | Closed Access

Multisite Controlled Study of OROS Methylphenidate in the Treatment of Adolescents With Attention-Deficit/Hyperactivity Disorder

160

Citations

39

References

2006

Year

Timothy E. Wilens, Keith McBurnett, Oscar G. Bukstein, James J. McGough, Laurence L. Greenhill, Marc Lerner, Mark A. Stein, C. Keith Conners, John C. Duby, Jeffrey H. Newcorn,

Archives of Pediatrics and Adolescent Medicine

Abstract

In adolescents, once-daily OROS methylphenidate significantly reduced ADHD symptoms and was well tolerated using dosages up to 72 mg/d.

References

	Year	Citations

Page 1